IBM Study: Chief Data Officers Redefine Strategies as AI Ambitions Outpace Readiness
81% of Chief Data Officers surveyed prioritize investments that accelerate AI capabilities…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…
Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel
Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health…
DXC Named a Leader in ISG Provider Lens AWS Ecosystem Partners Study
DXC receives 16 awards globally from ISG's assessment of AWS partners ASHBURN,…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
Safe Pros Artificial Intelligence Delivers 800+% Productivity Surge in Ukraine Demining Surveys According to Independent Research Presented at Leading Global Conference
Norwegian People’s Aid 18-Month Field Study from Ukraine Validates Safe Pro’s SpotlightAIâ„¢…
Descartes Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth
Automation and AI emerge as critical differentiators for logistics services providers facing…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing…